secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001641172-25-026187
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab launches Pediatric Health Assessment with multi-location Texas pediatric group
--------------------------------------------------------------------------------

- Tool integrates behavioral screeners (PSC-17, SDQ) with allergy/asthma metrics (CARAT) and OTC medication use.
- CEO Troy Grogan calls launch a 'significant commercial milestone' for QHSLab.
- IRB exemption granted for observational study evaluating allergy-behavior link and population health impact.
- Product targets back-to-school well-child visits, expanding recurring revenue model.
- Strategic positioning for potential pharma, payer, or public health partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000164117225026187/0001641172-25-026187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000164117225026187/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer